Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-IRCR-14-09-2019-10:03:04:004-480 - samples

ABSTRACT: Total of 180 gynecologic tumor specimens were subjected for targeted-exome and/or whole-transcriptome sequencing.

PROVIDER: EGAD00001005331 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

ena-DATASET-IRCR-29-12-2019-07:57:11:664-1458 - samples

Project description:Newly generated 52 gastric tumor specimens were subjected for targeted-exome and/or whole-transcriptome sequencing

| EGAD00001005766 | EGA

HG-14-10-04 KINOMEscan

Project description:For the panel of kinases, the percent of kinase bound by ligand is measured in the presence of HG-14-10-04 at 10 uM of concentration.

2015-10-06 | LDS-1120 | LINCS

ena-DATASET-IRCR-02-07-2015-09:52:05:548-46 - samples

Project description:We obtained paired longitudinal specimens from a total of 38 glioblastoma (GBM) patients (34 primary and 4 secondary GBM patients). Treatment-naive initial tumors were available for 35 cases; for the other 3 cases, we used the first available recurrent tumors in lieu of initial tumors. Tumor specimens were subjected to whole-exome sequencing (27 of 38 cases, with the matched normal/blood for 22 of the 27 cases) and transcriptome sequencing (30 of 38 cases).

| EGAD00001001424 | EGA

ena-DATASET-IRCR-11-07-2016-10:17:47:917-559 - samples

Project description:Total of 49 tumor specimens from 20 patients were subjected for whole-exome and/or whole-transcriptome sequencing including matched normal/blood. Tumor samples are acquired based on 4 categories; 1) locally adjacent tumors, 2) multifocal/multicentric tumors, 3) 5-ALA (+/-) tumors and 4) Longitudinal tumors.

| EGAD00001002248 | EGA

2024 09 04 Alexandre TRONEL PAPER 1

Project description:The gut microbiome is a complex ecosystem stratified that varies along different sections of the gut. It comprises a wide array of metabolites originating from both food, host, and microbes. Microbially-derived metabolites, such as bile acids, short-chain fatty acids, and indole derivatives, are of significant interest due to their direct interactions with host physiology and regulating function. Most current studies on the gut microbiome focus on fecal samples, which do not fully represent the upper parts of the gut due to its stratification. To collect microbiome samples from the proximal gut microbiome, endoscopic methods or new non-invasive medical devices can be used. To enable comprehensive profiling of the gut metabolome and analyze key metabolites, we developed a combined approach combining untargeted and semi-targeted metabolomics using a Q-Exactive Plus Orbitrap mass spectrometer. Initially, we selected 49 metabolites of interest for the gut metabolome based on four distinct criteria. We validated these metabolites through repeatability and linearity tests and created a compound database using the software TraceFinder (ThermoFisher Scientific). For untargeted metabolomics, we established a workflow for the annotation and discovery of molecules. Finally, 37 metabolites were validated for semi-targeted metabolomics, and we conducted a proof of concept on small intestinal and fecal samples form a clinical trial (NCT05477069). Our combined approach, facilitated by molecular networking, demonstrated the potential to discover new metabolites.

| MSV000095801 | MassIVE

Gene expression profiles of uterine leiomyosarcoma (ULMS)

Project description:Uterine leiomyosarcoma (ULMS) is a poorly understood gynecologic cancer with few effective treatments. This study explores molecular events involved in ULMS with the goal of identifying strategies. Genome-wide transcriptional profiling were used to compare clinically well-annotated specimens of myometrium, leiomyoma and leiomyosarcoma.

2012-04-26 | E-GEOD-36610 | biostudies-arrayexpress

ena-DATASET-IRCR-11-07-2017-02:57:13:607-145 - samples

Project description:Total of 584 tumor specimens and/or patient-derived cells across 14 cancer types were subjected for whole-exome/targeted-exome and/or whole-transcriptome sequencing.

| EGAD00001003441 | EGA

ena-DATASET-UNC-04-01-2018-14:59:10:908-675 - samples

Project description:Hepatocellular carcinoma specimens, intrahepatic cholangiocarcinoma specimens and liver normal tissues collected from 7 samples, including 44 fastq files from whole exome sequencing.

| EGAD00001003892 | EGA

ena-DATASET-IRCR-25-05-2016-07:12:37:756-31 - samples

Project description:We expanded our previous collection of longitudinal GBM patients (EGAS00001001041) by recruiting 21 additional patients. Tumor specimens were subjected to whole-exome sequencing (16 of 21 cases, with the matched normal/blood) and transcriptome sequencing (16 of 21 cases).

| EGAD00001002143 | EGA